-
Mashup Score: 10Cold air makes oxygen toxic for worms - 22 hour(s) ago
A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that microscopic worms exposed to frigid temperatures (about 36 degrees Fahrenheit) can survive up to 48 hours if they’re also exposed to low oxygen.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Campaign for Fred Hutch - 2 day(s) ago
Thanks to our generous supporters, Fred Hutch is redefining cancer and infectious disease for the next generation. Join us as we look beyond what’s possible today toward a new era of world-changing discoveries.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
As we mark our 50th anniversary in 2025, Fred Hutch is looking beyond what’s possible today to a new era of discovery. We invite you to explore 50 years of progress, discover our vision for the future and join the Campaign for Fred Hutch: https://t.co/fPJv9QOTMH https://t.co/jkaDYTvw3h
-
-
Mashup Score: 2Cold air makes oxygen toxic for worms - 4 day(s) ago
A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that microscopic worms exposed to frigid temperatures (about 36 degrees Fahrenheit) can survive up to 48 hours if they’re also exposed to low oxygen.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
In a new study published in @frontiersin, the Roth Lab in @HutchBasicSci showed that microscopic worms can survive extreme cold & low oxygen by triggering a survival mechanism. This could offer insights into how humans might endure similar conditions. https://t.co/DzF8DMkBIK
-
-
Mashup Score: 1The Beam: Dr. Annemarie Shepherd on proton therapy for thymic cancers; NAPT celebrates successes and meet Dr. Winston Vuong - 8 day(s) ago
What’s new in proton therapy? Read the latest news and views from Fred Hutch’s proton therapy facility’s patients and providers in The Beam, published monthly.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Excited to welcome Dr. Winston Vuong to Fred Hutch Proton Therapy @fhprotontherapy! Dr. Vuong specializes in genitourinary cancers and research on #biomarkers and cancer metastasis. Learn more about his work and passion for patient care: https://t.co/T3Z8dKweXX https://t.co/ZBSOujWmln
-
-
Mashup Score: 8Facts & Resources - 9 day(s) ago
Learn more about cervical cancer and find helpful resources
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Today, people facing #cervicalcancer have better treatment options with better outcomes than they did even a few years ago. Fred Hutch and @UWMedicine fellow, @RiosDoriaMD, shares the risk factors of cervical cancer and screening options available. https://t.co/7n1QnOPe4t https://t.co/2d86qxPKU1
-
-
Mashup Score: 11
After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of “seed” cells obtained from their donor.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
"The fact that there wasn’t a major difference can offer some comfort to physicians and patients by showing that [allogeneic] transplantation does not result in higher acquisition of mutations," said @masumi_ueda. https://t.co/Tm5fLRKIhk
-
-
Mashup Score: 3Going straight to the source in defense against infant RSV - 11 day(s) ago
Fred Hutch Cancer Center scientists developed an engineered antibody that may be able to target immune cells capable of producing a protective response against RSV. The work could pave the way toward an infant RSV vaccine that helps build their immunity while sidestepping the downsides of prior attempts.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Respiratory virus season is in full swing, and Infants need extra protection against #RSV. A recent study from @McGuire_Lab suggests a novel vaccine strategy that could activate infants' immune systems right after birth. https://t.co/FoESHFJRUn
-
-
Mashup Score: 2Starting the year smarter - 11 day(s) ago
To start the year right, Fred Hutch scientists, providers and a patient advocate share tips to help readers keep up with the deluge of health and science information.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
How do we keep up with the deluge of health and science information coming at us? And what about #AI? Fred Hutch scientists, providers and a patient advocate share their pointers on how to stay in the know: https://t.co/HeaP2FPDNj
-
-
Mashup Score: 11
After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of “seed” cells obtained from their donor.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
"The fact that there wasn’t a major difference can offer some comfort to physicians and patients by showing that [allogeneic] transplantation does not result in higher acquisition of mutations," said @masumi_ueda. https://t.co/Tm5fLRKIhk
-
-
Mashup Score: 1850 years of doing hard things - 12 day(s) ago
In just 50 years, Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for its expertise in molecular biology, tumor virology and infectious diseases, as well as the coordination of large-scale clinical and epidemiologic studies.
Source: www.fredhutch.orgCategories: General Medicine News, Hem/OncsTweet-
Great history of @fredhutch- how it was started 50 years ago https://t.co/4Lb45OsXwI via @fredhutch
-
In a new study published in @frontiersin, the Roth Lab in @HutchBasicSci showed that microscopic worms can survive extreme cold & low oxygen by triggering a survival mechanism. This could offer insights into how humans might endure similar conditions. https://t.co/DzF8DMkBIK